The efficacy and safety of bevacizumab combined with FOLFOX regimen in the treatment of advanced colorectal cancer: A systematic review and meta-analysis

BACKGROUND: It is necessary to systematically evaluate the clinical efficacy and safety of bevacizumab (BEV) combined with 5-fluorouracil + leucovorin + oxaliplatin (FOLFOX) regimen in the treatment of advanced colorectal cancer. METHODS: We searched the PubMed et al databases for randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hailing, You, Jinzhi, Liu, Wei, Chen, Dandan, Zhang, Shiqi, Wang, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322501/
https://www.ncbi.nlm.nih.gov/pubmed/34397704
http://dx.doi.org/10.1097/MD.0000000000026714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322501/
https://www.ncbi.nlm.nih.gov/pubmed/34397704
http://dx.doi.org/10.1097/MD.0000000000026714

Ejemplares similares